In Norway, drug-related research covers drugs, alcohol, tobacco and, to a certain extent, gambling and performance-enhancing drugs. The drugs and alcohol field is one of the priorities of the government’s investment in research and falls within the objectives of improving quality and developing skills in the drugs and alcohol field. Within the current national action plan, there is a section devoted to drug-related research. In general, the government assesses the need to increase knowledge about the effectiveness of the interventions and treatment that are offered to people with drug dependencies.
Recent studies include population-based and clinical epidemiology research, basic biological, neurobiological and behavioural research and drug policy research.
The main sources of funding for these research activities are government departments, partly through the Research Council of Norway and partly through the Directorate of Health. Studies are mainly conducted by the Norwegian Centre for Addiction Research (SERAF) and the Norwegian Institute of Public Health, as well as some university departments and privately funded research institutes. Research findings are disseminated through several websites and through scientific and nonscientific national and international journals.
Drugs and alcohol research is one of the priorities of the government’s investment and falls within the objectives of improving quality and developing skills in the drugs and alcohol field